Pediatric Pulmonology Year in Review 2015: Part 1 by Auten, Richard et al.
  
 
 
 
Edinburgh Research Explorer 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Pediatric Pulmonology Year in Review 2015: Part 1
Citation for published version:
Auten, R, Schwarze, J, Ren, C, Davis, S & Noah, TL 2016, 'Pediatric Pulmonology Year in Review 2015:
Part 1', Pediatric Pulmonology. https://doi.org/10.1002/ppul.23423
Digital Object Identifier (DOI):
10.1002/ppul.23423
Link:
Link to publication record in Edinburgh Research Explorer
Document Version:
Peer reviewed version
Published In:
Pediatric Pulmonology
Publisher Rights Statement:
Author's final peer-reviewed manuscript as accepted for publication
General rights
Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s)
and / or other copyright owners and it is a condition of accessing these publications that users recognise and
abide by the legal requirements associated with these rights.
Take down policy
The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer
content complies with UK legislation. If you believe that the public display of this file breaches copyright please
contact openaccess@ed.ac.uk providing details, and we will remove access to the work immediately and
investigate your claim.
Download date: 11. May. 2020
1 
 
 
Pediatric Pulmonology Year in Review 2015: Part 1 
Richard Auten1, Jurgen Schwarze2, Clement Ren3, Stephanie Davis3, Terry L. Noah4 
1. ConeHealth System, Greensboro NC, USA, richard.auten@conehealth.com 
2. Dept. of Child Life and Health, The University of Edinburgh, Edinburgh, UK   
jurgen.schwarze@ed.ac.uk 
3. Riley Children's Hospital, Indiana University School of Medicine, Dept. of Pediatrics, Indianapolis, IN 
USA sddavis3@iu.edu 
4. Dept. of Pediatrics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA 
terry_noah@med.unc.edu 
 
Correspondence: Terry L. Noah at terry_noah@med.unc.edu;  450 Macnider Building, Campus Box 7217, 
University of North Carolina, Chapel Hill, NC 27599-7217.  Facsimile (919) 966-6179, telephone (919) 
966-1055.  
 
Word count:  3411 
  
2 
 
ABSTRACT 
Our journal covers a broad range of research and scholarly topics related to children’s respiratory 
disorders.  For updated perspectives on the rapidly expanding knowledge in our field, we will summarize 
the past year’s publications in our major topic areas, as well as selected publications in these areas from 
the core clinical journal literature outside our own pages.  The current review covers articles on neonatal 
lung disease, pulmonary physiology, and respiratory infection. 
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Introduction 
Our journal covers a broad range of research and scholarly topics related to children’s 
respiratory disorders.  For updated perspectives on the rapidly expanding knowledge in our field, we will 
summarize selected publications from the past year in our major topic areas, as well as selected 
publications in these areas from the core clinical journal literature outside our own pages.  The current 
review covers articles on neonatal lung disease, pulmonary physiology, and respiratory infection.    
 
Neonatal lung disease and bronchopulmonary dysplasia (BPD) 
Bronchopulmonary Dysplasia (BPD) and its Etiology 
Premature birth has implications for long term health even without well-known complications 
like BPD, a well-established exacerbating factor for adverse pulmonary and neurodevelopmental 
outcomes.  This continues to motivate the search for preventive strategies based on improved 
mechanistic insights, as well as more accurate descriptions of long-term pulmonary health effects, 
among others.  
Clinical studies have made it clear that BPD is multifactorial and that multiple gene families 
contribute to increased BPD risk.  BPD and prematurity are important predisposing factors for later 
susceptibility to sequelae of respiratory insults such as COPD.  The developmental window(s) of 
vulnerability and the threshold magnitude of oxidative stress have been explored in a variety of animal 
model systems.  Maduekwe et al. tested the concept that accumulated hyperoxia exposure during 
neonatal and juvenile lung development (time x concentration) in mice would predict susceptibility to 
adult influenza-induced lung injury1.  While a minimum FiO2 of 0.6 appeared to be required, it is not yet 
certain that early postnatal hyperoxia (postnatal days 4-8) is required for the phenotype of alveolar 
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enlargement and aberrant elastin deposition in adult mice.  Knaapi et al. 2 report that overexpression of 
cathepsin K, a protease implicated in inflammatory lung conditions such as BPD, in transgenic mice has 
some limited protective effects during neonatal hyperoxia exposure.  Limiting the damage from positive 
pressure ventilation has been widely proposed and embraced, with a trend towards using volume-
targeted SIMV.  Musk et al. treated surfactant deficient premature lambs with synchronized intermittent 
mandatory ventilation (SIMV) or high frequency jet ventilation (HFJV) using a volume targeted approach 
(7 mL/kg) for SIMV breaths in both treatment groups 3.  Although HFJV is designed to minimize airway 
pressure amplitude (∆P) at the level of the alveoli, they reported no differences in gas exchange, 
pulmonary blood flow, or histologic evidence of lung injury between the two ventilation groups.  The 
duration of the study was 180 minutes and the lambs were anesthetized with propafol and remifentanil, 
so it may be that differences between ventilation approaches would have emerged with longer duration 
and less sedation that would be typical in clinical applications.  As in the clinical trials of mechanical 
ventilation approaches in ARDS, using an open-lung approach 4 while avoiding overdistension may be 
the key to minimizing lung injury attributable to mechanical ventilation. 
Host susceptibility factors based on genotype have been shown to be relevant for experimental 
BPD. Huusko and colleagues5 report for the Gen-BPD Study group that Kit ligand gene polymorphisms in 
humans are significantly associated with risk for BPD and importantly that elevations of Kit ligand 
protein in umbilical cord blood also confer elevated BPD risk. Because of the role of the Kit pathway in 
mast cell maturation and proliferation, elevated cord blood Kit ligand may be identifying pro-
inflammatory conditions in utero, which are known to increase BPD risk. 
As noted in the 2014 Year in Review, center effect is a profound determinant of BPD risk 6 and 
there are numerous attempts to better characterize those at greatest risk early in their courses of 
treatment in order to intervene at the right time.  A variety of so-called BPD risk scores have been 
developed to partly address this need.  A single center study reported by Malkar et al. 7confirmed earlier 
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reports that elevated respiratory severity at age 30 days, calculated as FiO2 x mean airway pressure, was 
predictive of mortality, which is unsurprising given that persistent need for mechanical ventilation at age 
30 days would identify a very high risk group.  As the authors pointed out, caution must be exercised 
when generalizing predictive scores obtained from a single center, particularly if the mortality or BPD 
risk in the center were skewed in some way.   
Efforts to limit and optimize mechanical support have led to wider use of non-invasive positive 
pressure ventilation, albeit with limited high-quality data to guide its use.    Li and colleagues 8 report in 
a review and meta-analysis that NIPPV has not been shown to decrease the need for IPV, hastening to 
add that a sufficiently powered prospective study has yet to be conducted. A pilot study by Kugelman 
and colleagues 9 takes a step in that direction by comparing the efficacy of nasal IPPV versus humidified 
high flow (1-5 LPM) nasal cannula (HFNC) to prevent intubation, and suggesting that HFNC may be as 
effective as IPPV Two limitations of the study are worth noting.  First, the proportion of eligible patients 
actually enrolled was relatively small (76/293).  Second, the choice of the flows delivered via HFNC were 
not systematically chosen by specified criteria.    When patients do require endotracheal intubation, 
predicting successful extubation should limit further injury by limiting the need to re-recruit, and earlier 
extubation may improve outcomes 10 Robles-Rubio et al. report an improved computational approach to 
respiratory inductance plethysmography that predicts extubation readiness in preterm newborns 
undergoing mechanical ventilation, observing that diminished variability of respiratory effort predicts 
failure 11.  It is unclear whether low variability represents immaturity of neural signaling, diaphragmatic 
responsiveness or some combination.  The authors speculate that the combination of decreased air flow 
variability and increased rib cage movement variability may signal relatively ineffective respiratory 
behaviors. 
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Prematurity: Pulmonary Sequelae  
2015 was a particularly fertile year for publication of late pulmonary outcomes of prematurity in 
Pediatric Pulmonology.  Thunqvist et al. 12 report results from a longitudinal cohort of patients 
diagnosed at 36 weeks with moderate or severe BPD from a single center (N=55).  Mechanics measured 
using the raised volume rapid thoracoabdominal compression (RVRTC) method showed similarly 
impaired volumes and compliance in both moderate and severe BPD at age 18 months relative to 
published age-matched standards.  This is at odds with other studies that have shown greater impacts of 
disease severity on lung function, but the methodologic variations and validity of so-called normal 
standard values were discussed in detail by the authors.  Ronkainen et al. 13 used a similar approach 
comparing conventional spirometry and diffusion tests (DLCO) in 88 unsedated older children (10-11.5 
yr) that were born before 32 weeks gestation with 88 similar age controls born at term. In line with the 
early childhood results, airflow limitations and diminished diffusion capacity were prevalent in preterm 
born children, and worse in those diagnosed with BPD compared with control subjects.  These effects of 
prematurity on diffusion in older school age children differed from the results reported by Assaf et al. 14 
among sedated three year olds, which showed no effect of prematurity on DLCO. It must be noted that 
Assaf et al. studied healthy prematures only, at a gestational age of 31.7 weeks, meaning those 
unaffected by significant lung disease, thus a less vulnerable population.   
Using spirometry, Gibson and colleagues measured pulmonary function in adults born as very 
low birth weight (VLBW) newborns in the late 1970’s to early 1980’s 15.  Airflow limitations were present 
in the VLBW group compared with those with birthweight ≥ 2.5 kg, with a more pronounced decrement 
in those diagnosed with BPD.  FEV1 in VLBW adults were more predictive of adult FEV1 than was the 
case with normal BW adults.  Jiang et al. 16 and Nève et al. 17 contributed to addressing the need for 
more normative data by assessing pulmonary function in normal school-age subjects in their respective 
populations.  The long-term clinical implications of the apparent deficits in lung function among adult 
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survivors of premature birth, particularly those diagnosed with BPD, is not yet clear, but may be more 
severe than earlier appreciated, as reviewed by Ronkainen and colleagues 13. 
In a retrospective study, Cristea et al. reported clinical data on a cohort of infants with 
bronchopulmonary dysplasia (BPD) who were ventilator dependent; these investigators reported that 
this population had severe airway obstruction that remained unchanged over time 18.  These findings 
suggest that children with a history of severe BPD have substantial impairment in lung function that will 
likely persist into adulthood, placing them at increased risk for future chronic obstructive lung disease.   
 
Lung Hypoplasia: Pulmonary Sequelae 
Congenital diaphragmatic hernia represents a severe interruption of lung development in many 
cases.  Although some may be asymptomatic, others may suffer fatal pulmonary hypoplasia.  Survivors 
that required lengthy courses of mechanical ventilation may be at particularly high risk for abnormal 
long-term lung function. Healy and colleagues 19 analyzed pulmonary function using RVRTC and whole 
body plethysmography in sedated CDH survivors during infancy (6 and 18 months) and found higher 
lung volumes and airway resistance in children with CDH complicated by pulmonary hypertension (PH).  
As the authors noted, this is consistent with prior reports of enlarged, simplified alveolar structure that 
accompanies disrupted pulmonary vascular development in CDH-associated PH.  An important addition 
from this study is the observation of longitudinal evaluations, at least in a subset of subjects. In those for 
whom longitudinal data were obtained, the PH-associated elevations in lung volumes persisted over 
time.  Similar findings were noted by Panitch and colleagues 20 who used similar methods.  They 
reported that abnormalities persisted up to three years, with severity correlating with the magnitude of 
presumed hypoplasia (surrogates being the need for patch closure, duration of mechanical ventilation, 
need for ECMO).  The ‘catch up’ potential for lung growth may be durably impaired in those with severe 
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hypoplasia, often accompanied by persistent PH, possibly reflecting a decreased repertoire of functional 
progenitor cells.  The approach to ameliorating pulmonary hypoplasia in this disease has suffered from a 
dearth of mechanistic studies as outlined by a review of pre-clinical studies by Eastwood et al. 21  The 
authors underscore the need for common outcome measures to enable proper comparisons among the 
therapeutic approaches. 
 
Pulmonary physiology 
Physiologic measurements play a critical role in the care and study of pediatric respiratory 
diseases.  In order for physiologic data to be useful, proper acquisition is imperative and robust normal 
reference data must be available for comparison 22.  In a study of infants with cystic fibrosis, 
Anagostopoulou et al. 23 reported that lung clearance index (LCI) values were falsely normal when 
obtained using multiple breath washout (MBW) measurements of sulfur hexafluoride (SF6) with 
commercial equipment.  MBW calculates LCI by tracing the molar mass of SF6 as it falls from 100% to 
2.5%.  The algorithm in commercial software utilizes end-inspiratory molar mass to define the initial 
100% step in gas concentration.  The investigators developed a refined algorithm that utilizes end-
expiratory molar mass instead, resulting in more accurate LCI determination.  In a study of flow 
dependence of specific airway resistance (sRaw) measurement using whole body plethysmography, 
Coutier et al. demonstrated that sRaw can be affected by the range of flows generated during the 
panting maneuver used to measure sRaw; narrowing this flow interval allowed better discrimination 
between asthma and normal children 24.   
Low and middle income countries have a heavy burden of infant respiratory disease, but 
resources and environment in these countries limit the ability to use conventional techniques for 
sedated infant lung function testing.  Gray et al. conducted a pilot study in a semi-rural area of South 
9 
 
Africa demonstrating the feasibility of obtaining tidal breathing recordings, exhaled nitric oxide, and 
multiple breath washout data in unsedated infants 25. Obtaining data outside of the pulmonary function 
laboratory will allow for the collection of a larger and more diverse set of normal reference values, 
which increases the possibility of furthering our understanding of infant respiratory morbidity in third 
world countries.   
 Tidal breathing analysis is an especially appealing technique since it is non-invasive, does not 
require sedation and only minimal cooperation is needed to assess respiratory function 26.  In children 
following surgical repair of congenital diaphragmatic hernia, Laviola et al. used opto-electronic 
plethysmography to study thoraco-abdominal asynchrony and reported that diaphragmatic patching is 
associated with less asynchrony (or abnormality) compared to the primary suture approach to 
management 27.  Further study is required to determine if these findings are clinically relevant.  Using 
respiratory inductance plethysmography (RIP) and measurement of the electrical activity of the 
diaphragm, Pham et al. demonstrated that high flow nasal cannula (HFNC) therapy in infants with 
bronchiolitis resulted in decreased work of breathing 28.  These findings support the use of HFNC in 
bronchiolitis, suggesting that RIP may provide an objective measure of the effect of HFNC on respiratory 
mechanics in this group of patients.   
 Preterm birth often leads to disrupted alveolar-capillary development 29.  Assaf et al. measured 
the diffusion capacity of the lung for carbon monoxide in healthy preterm (HP) infants and normal full 
term infants 14 .  Surprisingly, DLCO was actually higher in HP infants compared to normal controls, and 
not associated with gestational age or duration of mechanical ventilation after adjusting for body length, 
sex, and race.  However, a higher DLCO was associated with an increased number of pro-angiogenic 
circulating hematopoietic stem/progenitor cells and treatment with CPAP; thereby, identifying potential 
novel approaches for treatment and monitoring of preterm lung disease.  Although most preterm 
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infants receive respiratory support for only the first few weeks of life, some infants require long term 
mechanical ventilation, and little is known about their lung function.   
 Physiologic measurements also provide insight into the pathogenesis of different pediatric 
respiratory diseases.  Mayer et al. prospectively performed modified spirometry in a cohort of patients 
with Duchenne muscular dystrophy and showed a rate of decline in forced vital capacity of 
approximately 5 %-predicted points per year between the ages of 5 to 24 years 30.  These data will be 
helpful in calculating sample sizes for future interventional trials.  In 5 to 7 year old children previously 
hospitalized for bronchiolitis as infants, Lauhkonen et al. 31 performed impulse oscillometry and found 
that persistent severe deficits were present in only a small minority of study subjects, suggesting that 
permanent lung function reduction associated with infantile bronchiolitis occurs in later childhood.   
 
Respiratory infection 
Viral infections 
Viral lower respiratory tract infection (LRTI) in young children continues to be of intense 
research interest, not least because since it may predispose to asthma and decrements in lung function 
in later life. Studies of risk factors for severe LRTI found that increased levels of maternal folate in mid 
pregnancy are associated with a decreased risk of LRTI by 6 months of age, and correlate with cord 
blood IL-10 levels and inversely with cord blood eosinophil counts 32, while bronchiolitis cases with blood 
eosinophilia had an increased length of hospital stay (LOS) and were more often mechanically ventilated 
(24.2%) than those without eosinophilia (7.2%) or without blood counts (0.7%) 33. Geographic clustering 
of LRTI cases identified air pollution and poor housing as community level risk factors for wheezing LRTI 
and viral LRTI, respectively, with higher socio-economic status reducing the risk 34.  Such community 
level risk factors may enable multifaceted interventions in communities to reduce childhood LRTI. 
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RSV immune prophylaxis efficacy was studied retrospectively in several populations. In children 
with CF, routine RSV-prophylaxis significantly reduces RSV hospitalizations but has no impact on lung 
function and growth at 6 years of age 35.  In children with congenital heart disease, RSV prophylaxis 
significantly reduces all LRTI, LRTI-hospitalizations, and intensive care admissions 36, but it does not seem 
to have an effect on hospitalizations in children with idiopathic lung disease, who have more frequent 
and longer RSV-hospitalizations than healthy children 37.  
Current ‘hot topics’ in bronchiolitis management include hypertonic saline (HS) inhalation, non-
invasive ventilation (NIV), and O2-saturation targets.  An RCT in 68 infants with hospitalized bronchiolitis 
compared 3%HS to normal saline inhalation, both given with salbutamol, and did not find any difference 
in LOS or severity scores, but more cough and rhinorrhea after HS 38. These findings do not support 
routine HS use in bronchiolitis, in keeping with 2 recent larger RCTs 39,40 and a systematic review with 
meta-analysis 41.   Noninvasive ventilation (NIV) is often used in acute bronchiolitis. Assessment of 
diaphragmatic electrical activity and esophageal pressure changes showed that high flow nasal cannula 
therapy offloads the diaphragm and reduces work of breathing in bronchiolitis 42.  However, in a 
multicenter prospective audit NIV did not reduce the need for endotracheal intubation and ventilation 
in ex-premature infants (32-35 weeks of gestation) with bronchiolitis 43, suggesting that further studies 
of NIV outcomes are required.   Despite a recommended 90% O2 saturation target for children with 
bronchiolitis (American Academy of Pediatrics), clinical practice varies considerably often targeting 
higher O2 saturations. A recent multicenter equivalence RCT in acute bronchiolitis demonstrates that the 
90% O2-saturation target is safe and that it may reduce the time until infants requiring oxygen become 
fit for discharge 44.   
It remains important to better understand the risk factors for long term sequelae of early 
childhood LRTI.  In indigenous Australian infants, persisting symptoms at 3 weeks after acute 
bronchiolitis are associated with an increased risk for subsequent bronchiectasis, and previous 
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hospitalization and household smoke are risk factors for respiratory readmissions 45. Thus, optimized 
care following bronchiolitis and elimination of smoke exposure could improve long-term outcomes. The 
post-bronchiolitis risk of recurrent wheeze/asthma is modified by gender, with an increased risk in boys 
46, by excess weight at school age, but not by birth weight or excess weight in the first 1.5 years of life 47, 
and by polymorphisms in the TLR4, CD14, and IL-13 genes 48.    
 
Community acquired pneumonia and parapneumonic effusion 
 While viral infection remains the most common cause of community acquired pneumonia (CAP) 
in U.S. children 49, risk for bacterial infection and optimal use of antibiotics for severe CAP are still 
important issues worldwide.  Second hand smoke (SHS) is a well-known risk factor.  This was reinforced 
by a report from the Centers for Disease Control and Prevention's Etiology of Pneumonia in the 
Community study, in which children hospitalized with CAP from households with ≥2 smokers had a 
longer length of stay and were more likely to require intensive care compared with children from 
households with no smokers 50.   
Recommendations to use narrower spectrum antibiotics for CAP have resulted in declining use 
of cephalosporins in some areas 51.  However, interesting data were reported by Breuer et al. 52 who 
carried out a retrospective study of 337 children hospitalized with community acquired pneumonia 
(CAP) and compared outcomes between children treated with narrow spectrum antibiotics (penicillin, 
ampicillin, and amoxicillin) vs. broad spectrum antibiotics (ceftriaxone, cefuroxime, cefazolin).   Children 
treated more broadly had statistically shorter admissions and fever duration.   In a randomized placebo 
controlled trial, administration of azithromycin early in the course of illness significantly reduced 
severity of subsequent lower respiratory tract illness, in preschool children with histories of recurrent 
illness 53; whether this is related to antimicrobial or anti-inflammatory effects is unclear.  The Tucson 
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Children’s Study group reported evidence that early pneumonia may be among the most important 
early life risk factors for adult lung disease 54.   
Parapneumonic effusion (PPE) is an important and common complication of bacterial 
pneumonia, and its optimal management is still debated.  Kontouli et al. 55 reported on lung function 
and exercise capacity outcomes 2 years after PPE in a prospective study of 51 children, and found lower 
FVC % predicted, FEV1 % predicted, and FEV1/FVC in these children compared to healthy controls, but 
these changes were not felt to be clinically important.  In another prospective study 56, children < 16 
years hospitalized with CAP were followed prospectively and 25% developed PPE.  Not surprisingly, 
evidence of bacterial infection was associated with increased risk for PPE.  Interestingly, ibuprofen use 
prior to admission was also associated with increased PPE risk.  Finally, Hanson and colleagues 57 carried 
out an elegant prospective crossover trial in which children with PPE (mean age 3.5 yr) referred to 
interventional radiology were randomized to one of two regimens involving fibrinolysis with alteplase 
0.1 mg/kg twice a day alternating with normal saline twice a day.  Effusion volumes were followed with 
low dose CT. Alteplase resulted in reduction in PPE volumes compared to normal saline; and earlier 
administration of alteplase (days 1 and 3) also performed better than later (days 2 and 4).  
 
Conclusions 
 In the past year, many articles have been published in Pediatric Pulmonology and elsewhere, to 
further advance our understanding of neonatal lung disease, pediatric pulmonary physiology, and 
respiratory infection in children.   Subsequent articles in this Year in Review series will cover sleep and 
breathing disorders, cystic fibrosis, asthma, infection, diagnostic testing, rare lung diseases, and 
neuromuscular disorders. 
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